Medicare Expands Coverage of Prolaris, Genetic Test for Prostate Cancer Aggressiveness June 2, 2017 Medicare coverage for Prolaris genetic test, a tool developed by Myriad Genetics to help predict the aggressiveness of prostate, cancer has been expanded to include patients with favorable intermediate-risk cancer.Read more. Source: Prostate Cancer News Today Prostate Cancer News
Medicare coverage for Prolaris genetic test, a tool developed by Myriad Genetics to help predict the aggressiveness of prostate, cancer has been expanded to include patients with favorable intermediate-risk cancer.Read more. Source: Prostate Cancer News Today
